Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fagopyrum dibotrys extract is a traditional Chinese medicine (TCM) derived from the rhizome of wild buckwheat (*Fagopyrum dibotrys*). It is primarily formulated as a capsule and is widely used in China for its anti-inflammatory, antibacterial, and antitussive properties. The extract contains active components such as total flavonoids and condensed tannins, which are believed to inhibit inflammatory mediators and exhibit direct activity against respiratory pathogens. It is clinically indicated for the treatment of purulent respiratory conditions, including lung abscesses, chronic bronchitis, and acute tonsillitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fagopyrum dibotrys extract.